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for 28 days, then the systolic, diastolic, mean pulmonary artery pressure (PASP,
PADP, mPAP) and right ventricle hypertrophy index (RVHI) were measured; the
pathological changes of small pulmonary arteries were observed, the thickness index
(TI) and area index (AI) of the small pulmonary arteries in three groups were eval-
uated with microscopy for morphological analysis; echocardiography measuring the
internal diameters of the pulmonary trunk assessed pulmonary hypertension in three
groups.
Results:①The PAP(PASP, PADP, mPAP) and RVHI in air embolism group were all
signiﬁcantly higher than these in control group, respectively (P<0.05), and these in
nicorandil treated group were signiﬁcantly lower than these in air embolism group,
respectively (20.473.91 mmHg VS 32.373.00 mmHg, 9.351.48 mmHg VS
13.491.62 mmHg, 13.741.86 mmHg VS 21.931.10 mmHg and 0.310.03 VS
0.470.13 P<0.05).②The thickness of wall increased and the cavity became narrow
in the small pulmonary arteries of air embolic group, and these were signiﬁcantly
ameliorated in the small pulmonary arteries of nicorandil treated group. The TI and AI
in the small pulmonary arteries of air embolic group were signiﬁcantly higher than
these in control group, respectively (P<0.05), and these in the small pulmonary
arteries of nicorandil treated group were signiﬁcantly lower than these in air embolic
group, respectively (0.380.12 VS 0.750.13, 0.600.16 VS 0.930.09 P<0.05).
③The internal diameters of the pulmonary trunk was higher in air embolic group
than that in control group(P<0.05); That was redused in nicorandil treated
group(0.780.06cm VS 0.930.14cm, P<0.05).
Conclusions: Nicorandil can signiﬁcantly attenuate the chronic air embolism-induced
pulmonary hypertension, improve pulmonary vascular remodeling of the small
pulmonary artery and right ventricular hypertrophy and reduse the internal diameters
of the pulmonary trunk.
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Objectives: High-density lipoprotein (HDL) cholesterol levels are a strong, inde-
pendent inverse predictor of cardiovascular disease. The present study aimed to
determine whether serum HDL cholesterol levels correlated with disease severity and
clinical outcomes in patients with idiopathic pulmonary arterial hypertension (IPAH).
The present study aimed to determine whether serum HDL cholesterol levels corre-
lated with disease severity and clinical outcomes in patients with idiopathic pulmonary
arterial hypertension (IPAH).
Methods: The serum HDL cholesterol levels were measured in 76 Chinese patients
with IPAH and 45 healthy controls, together with other clinical variables. Univariate
and multivariate Cox proportional hazards analysis was performed to assess the
prognostic value of HDL cholesterol and event-free survival. Event-free survival was
estimated using the Kaplan-Meier method.
Results: Serum HDL cholesterol levels were signiﬁcantly decreased in patients with
IPAH compared with controls (1.00.3 vs 1.50.3 mmol/L; P<0.001). The serum
HDL cholesterol levels decreased in proportion to the severity of World Health
Organization functional class. Compared to the high HDL cholesterol group, the low
HDL cholesterol group demonstrated a signiﬁcantly lower 6-minute walking distance,
cardiac index, mixed venous saturation, and arterial carbon dioxide pressure but
signiﬁcantly greater pulmonary vascular resistance and serum uric acid levels. The
serum HDL cholesterol levels correlated positively with the cardiac index (r¼0.42;
P¼0.002) and negatively with the pulmonary vascular resistance (r¼-0.25; P¼0.04).
Serum HDL cholesterol was independently related to event-free survival on multi-
variate Cox proportional hazards analysis. Kaplan-Meier survival curves according to
the median HDL cholesterol value showed that lower HDL cholesterol levels were
associated with lower event-free survival.
Conclusions: Serum HDL cholesterol levels might serve as an indicator of disease
severity and prognosis in patients with IPAH.
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Objectives: For the diagnostic awareness of acute pulmonary thromboembolism
(APTE) was increased in recent years, it became a relatively common cardiovascular
emergency. Because the pulmonary arterial bed is occluded by the thrombolus, usually
origenated from the deep vein of lower extrimities, an acute life-threatening right
ventricular failure might occur which could lead to severe shock and even death. It is a
difﬁcult diagnostic task for a clinician because of non-speciﬁc clinical presentation of
APTE. If early diagnosis were missed, the patients would die of acute right heart
failure, potentially fatal early recurrences or chronic right failure due to chronic
thromboembolic pulmonary hypertension. The clinical evaluation is important to
classify patients into probability categories corresponding to an increasing prevalence
of APTE.A prediction rule makes it possible to discriminate suspected APTE patientsJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Cfor clinicians, that has become a key step in all diagnostic algorithms for APTE. The
most frequently used clinical prediction rule is Wells score that is based on early
clincal manifestations.But the reproducibility was variable due to one subjective item
in the rule (alternative diagnosis less likely than APTE). Thus the usefullness of Wells
score was limited. For the different medical system and policy of medical insurance
between western countries and China, it is much easier to collect ECG and echo-
cardiography information for Chinese physicians. In this study, the diagnositic pro-
bablity of suspected APTE based on the objective clinical tests was researched.
Methods: 425 consecutive cases of suspected APTE were enrolled, which included
161 conﬁrmed cases and 264 excluded cases according to the result of CT pulmonary
angiography. The items in Wells score including risk factors, symptoms and signs, and
two objective variables: electrocardiography (ECG) and echocardiography were
studied by Logistic multiple regression analysis.
Results: The odd ratio and 95% CI of the parameters above were: history of APTE or
deep venous thrombosis (DVT) 3.22 (1.13-5.20); Recent surgery or immobilization
2.66 (1.28-4.12); cancer1.34 (0.58-2.50); hemoptysis2.85 (1.14-4.97); heart rate >100
beats/min 1.02(0.93-1.40); clinical signs of DVT 2.28 (1.24-3.01); abnormal ECG
including negative T wave of lead V1-V4 or SIQIIITIII 2.21 (1.55-3.81); abnormal
echocardiography including dilation of right ventricle or increased estimated systolic
pulmonary arterial pressure 1.95 (1.30-3.18), P<0.05 respectively.
Conclusions: The abnormal ECG and echocardiography were risk factors for the
diagnosis of APTE, could be objective evidence for item ‘alternative diagnosis less
likely than APTE’ in Wells score for APTE. It might make Wells score operatable and
reproducible.
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Objectives: Studies have demonstrated that rennin angiotension system is involved in
the pathogenesis and development of pulmonary arterial hypertension (PAH). How-
ever, it is controversial whether angiotensin II type I receptor blockers attenuate PAH.
Here we examined the prevention effects of valsartan on experimental rodents of
PAH.
Methods:Male Sprague-Dawley rats with monocrotaline-induced PAH and male C57
mice with hypoxia-induced PAH were administered oral valsartan for 3 weeks.
Heamodynamic and anatomic data were determined in rats and mice. Histopathology,
immunohistochemistry, assessments of cell proliferation and stabilization of extra-
cellular matrix were performed in lung tissue of rats.
Results: In comparison with control rodents (rats and mice), valsartan markedly
improved the survival and decreased the RV systolic pressure and RV hypertrophy
index. Masson’s trichrome staining and immunohistochemical analyses revealed that
valsartan suppressed cell proliferation, attenuating the pulmonary vascular remodel-
ing. Further, western blot showed that valsartan inhibited the enhanced p38, JNK1/2
and ERK1/2 phosporylation in PAH rats. Similarly, active matrix metalloproteinase-2
(MMP-2) and MMP-9 were signiﬁcantly attenuated by valsartan. Furthermore, val-
sartan signiﬁcantly reduced the increase of TGF-b1 in rat lung tissue.
Conclusions: These results suggest that valsartan attenuates the progression of
PAH via inhibition of cell proliferation and MMPs expression and activity in
experimental rodents. Thus, valsartan might be a valuable prevention therapeutic
approach for PAH.
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Objectives: The American Collage of Chest Physicians indicated that infection is a
risk factor for VTE. And Inegrin aIIbb3, a kind of platelet membrane glycoprotein, is
the key factor affecting platelet activation. The aim of this study was to investigate the
gene expression correlation of cytokines and platelet activation-related mRNAs in
peripheral blood mononuclear cells between patients with symptomatic PE.
Methods: Twenty cases of PE patients and twenty sex and age matched controls were
recruited into the study. Human cDNA microarray analysis, random variance model
corrected T test and multiple linear regression analysis were used to analyze the
statistical data.
Results: (1) Fourteen platelet membrane glycoprotein mRNAs were detected. In PE
patients, 7 of them includingITGA2B and ITGB3 were up-regulated signiﬁcantly in
the PE group (P<0.01). 2). One hundred and twelve mRNAs of chemokines, in-
terleukins, colony-stimulating factors, interferons and tumor necrosis factors wereardiovascular-Disciplinary Research C217
